Yecuris is a leading brand that specializes in providing next-generation tools for hepatic research and discovery. At the core of their offerings are FRG® humanized mice, which bring unprecedented physiological relevance to research programs. They also offer a wide range of preclinical research services, including gene editing and gene therapy, NASH and NAFLD studies, and infectious disease research.

The Yecuris FRG® KO platform is a game-changer for researchers, allowing them to significantly cut down their discovery time. With its patented technology, this platform has been trusted by researchers for over a decade in various applications such as gene and cell therapy optimization, infectious disease testing, and NASH compound assessment. Yecuris offers a complete platform for researchers, supporting in vitro development and optimization to in vivo validation.

Whether researchers are working on innovative gene and cell therapies or testing small molecules for metabolism and toxicology, Yecuris provides the necessary tools and expertise. With Yecuris, researchers can expect accurate, relevant, and human-centered solutions for their hepatic research needs